2-methyl-1H-pyrrole-3-carbaldehyde | 17619-39-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-methyl-1H-pyrrole-3-carbaldehyde
• 英文别名: formyl-3 methyl-2 pyrrole；2-methyl-pyrrole-3-carbaldehyde；2-Methyl-3-pyrrolcarbaldehyd；2-Methyl-3-formyl-pyrrol；3-Formyl-2-methyl-pyrrol
• CAS: 17619-39-5
• 化学式: C₆H₇NO
• mdl: MFCD11875996
• 分子量: 109.128
• InChiKey: JDFRRHGHHDDVOP-UHFFFAOYSA-N

物化性质

• 熔点：
  122 °C(Solv: benzene (71-43-2); hexane (110-54-3))
• 沸点：
  243.5±20.0 °C(Predicted)
• 密度：
  1.140±0.06 g/cm3(Predicted)
• 保留指数：
  2010.1;2090.9

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.166
• 拓扑面积：
  32.9
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  吡啶-3-磺酰氯 、 2-methyl-1H-pyrrole-3-carbaldehyde 生成 2-methyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde
  参考文献：
  名称：

  PROTON PUMP INHIBITORS

  摘要：

  公开号：

  EP1803709B1
• 作为产物：
  描述：

  [2-methyl-1-(phenylsulfonyl)-1H-pyrrol-3-yl]methanol 在 水 、 三氧化硫吡啶 、 三乙胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 二甲基亚砜 为溶剂， 反应 12.5h， 生成 2-methyl-1H-pyrrole-3-carbaldehyde
  参考文献：
  名称：

  Proton pump inhibitors

  摘要：

  公开号：

  EP2336107B1

文献信息

• [EN] PROTON PUMP INHIBITORS<br/>[FR] INHIBITEURS DE POMPE A PROTONS
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2006036024A1

  公开（公告）日：2006-04-06

  Proton pump inhibitors which have excellent proton pumping activity and which can be converted in vivo into proton pump inhibitors to exhibit antiulcer effect and so on, containing compounds represented by the general formula (I) or salts thereof or prodrugs of the same: (I) wherein X and Y are each independently a free valency or a spacer whose main chain has 1 to 20 carbon atoms; R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; R2, R3 and R4 are each independently hydrogen, an optionally substituted hydrocarbon group, optionally substituted thienyl, optionally substituted benzo[b]thienyl, optionally substituted furyl, optionally substituted pyridyl, optionally substituted pyrazolyl, optionally substituted pyrimidinyl, acyl, halogeno, cyano, or nitro; and R5 and R6 are each independently hydrogen or an optionally substituted hydrocarbon group.

  质子泵抑制剂具有优异的质子泵活性，可以在体内转化为质子泵抑制剂，表现出抗溃疡作用等，包含由通式（I）表示的化合物或其盐或类似物：（I）其中X和Y分别是自由价或其主链具有1至20个碳原子的间隔物；R1是可选择地取代的碳氢基团或可选择地取代的杂环基团；R2、R3和R4分别是氢、可选择地取代的碳氢基团、可选择地取代的噻吩基、可选择地取代的苯并[b]噻吩基、可选择地取代的呋喃基、可选择地取代的吡啶基、可选择地取代的吡唑基、可选择地取代的嘧啶基、酰基、卤素、氰基或硝基；R5和R6分别是氢或可选择地取代的碳氢基团。
• Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors
  申请人：Bosch Michael

  公开号：US20080269170A1

  公开（公告）日：2008-10-30

  The disclosure relates to compounds of formula (I): wherein R1-R5, A and Y are as defined in the disclosure, to compositions comprising said compounds, and to processes for making and methods of using the same.

  该披露涉及到式(I)的化合物：其中R1-R5、A和Y如披露中所定义，以及包含该化合物的组合物，以及制备该化合物的方法和使用该化合物的方法。
• Acid secretion inhibitor
  申请人：Kajino Masahiro

  公开号：US20070060623A1

  公开（公告）日：2007-03-15

  The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present invention provides a compound represented by the formula (I) wherein R 1 is a nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle, the nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle optionally has substituent(s), R 2 is an optionally substituted C 6-14 aryl group, an optionally substituted thienyl group or an optionally substituted pyridyl group, R 3 and R 4 are each a hydrogen atom, or one of R 3 and R 4 is a hydrogen atom and the other is an optionally substituted lower alkyl group, an acyl group, a halogen atom, a cyano group or a nitro group, and R 5 is an alkyl group or a salt thereof.

  本发明提供一种具有优越的抑制酸分泌作用并显示抗溃疡活性等的化合物。本发明提供一种由式(I)表示的化合物，其中R1是一种含氮的单环杂环基，可选择地与苯环或杂环缩合，该含氮的单环杂环基可选择地与苯环或杂环缩合，可选择地具有取代基，R2是可选择地取代的C6-14芳基，可选择地取代的噻吩基或可选择地取代的吡啶基，R3和R4分别是氢原子，或者R3和R4中的一个是氢原子，另一个是可选择地取代的较低烷基基团、酰基、卤原子、氰基或硝基，R5是烷基或其盐。
• Synthese de pyrroles et d'oxazoles par pyrolyse de N-(hydroxy-2′ ethyl) amino-3 propenoate
  作者：Catherine Pale-Grosdemange、Josselin Chuche

  DOI：10.1016/s0040-4020(01)81018-8

  日期：1989.1

  pyrolysis of various N-(2′-hydroxyethyl)-3-amino propenoates 1–6 and N-(2′-hydroxy-2′-phenyl ethyl)-3-amino propenoate 7–9 at 390°–420°C leads respectively to formylpyrroles 11–16 and benzoylpyrroles 17–19 and, in some cases, to substituted oxazoles 36–39. The results are best explained by the intermediate formation of dicarbonyl derivative followed either by an intramolecular thermal crotonisation

  各种N-（2'-羟基乙基）的气体热解PHAS -3-氨基propenoates 1 - 6和N-（2'-羟基-2'-苯基乙基）-3-氨基丙烯酸7 - 9在390℃-420 ℃，引线分别formylpyrroles 11 - 16和benzoylpyrroles 17 - 19，并且在一些情况下，为了取代的恶唑36 - 39。通过中间形成二羰基衍生物，然后在分子内进行热巴豆化反应或将偶氮甲ine叶立德分子进行6π电环化，可以最好地解释该结果。
• 1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITOR
  申请人：Kajino Masahiro

  公开号：US20090275591A1

  公开（公告）日：2009-11-05

  The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present invention provides a compound represented by the formula (I) wherein R 1 is a nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle, the nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle optionally has substituent(s), R 2 is an optionally substituted C 6-14 aryl group, an optionally substituted thienyl group or an optionally substituted pyridyl group, R 3 and R 4 are each a hydrogen atom, or one of R 3 and R 4 is a hydrogen atom and the other is an optionally substituted lower alkyl group, an acyl group, a halogen atom, a cyano group or a nitro group, and R 5 is an alkyl group or a salt thereof.

  本发明提供一种具有优异的抑制酸分泌作用并具有抗溃疡活性等的化合物。本发明提供一种由式（I）表示的化合物，其中R1是一种含氮的单环杂环基，可选择与苯环或杂环缩合，该含氮的单环杂环基可选择与苯环或杂环具有取代基，R2是可选择取代的C6-14芳基、可选择取代的噻吩基或可选择取代的吡啶基，R3和R4分别是氢原子，或者R3和R4中的一个是氢原子，另一个是可选择取代的低碳基、酰基、卤素原子、氰基或硝基，R5是烷基或其盐。

表征谱图